Artelo Biosciences Inc.

NASDAQ: ARTLW · Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM

Artelo Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Aug 31, 2021
Cash & Equivalents
6.89M 6.63M
Short-Term Investments
10.64M 3.44M
Long-Term Investments
-1.5M n/a
Other Long-Term Assets
3K 189K
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
789K 252K
Total Current Assets
18.32M 10.32M
Property-Plant & Equipment
60K 90K
Goodwill & Intangibles
2.04M 2.04M
Total Long-Term Assets
2.1M 2.32M
Total Assets
20.42M 12.63M
Account Payables
905K 493K
Deferred Revenue
n/a n/a
Short-Term Debt
40K 28K
Other Current Liabilities
53K 5K
Total Current Liabilities
998K 526K
Long-Term Debt
23K 67K
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
23K 67K
Total Liabilities
1.02M 593K
Total Debt
63K 95K
Book Value
n/a n/a
Book Value Per Share
n/a n/a
Common Stock
3K 25K
Retained Earnings
-31.02M -16.9M
Comprehensive Income
-254K 18K
Shareholders Equity
19.4M 12.04M
Total Investments
9.15M 3.44M